Peter Attia MD273 ‒ Prostate health: common problems, cancer prevention, screening, treatment, and more
At a glance
WHAT IT’S REALLY ABOUT
Urologist Ted Schaeffer Covers Prostate Problems From Urinary Symptoms to Cancer Care
- Schaeffer describes a stepwise approach to lower urinary tract symptoms, starting with behavioral changes, then alpha blockers, and then surgery such as HoLEP for lasting relief.
- Chronic pelvic pain and prostatitis are often not bacterial, and Schaeffer favors pelvic floor myofascial release and short-course anti-inflammatories over long antibiotic courses.
- Finasteride and dutasteride are portrayed as problematic because of post-finasteride syndrome and because they roughly halve PSA, which can mask aggressive cancer.
- Attia and Schaeffer argue that baseline and regular PSA testing, advanced PSA markers, PSA density, and a pre-biopsy MRI make prostate cancer screening far more precise than critics claim.
- Treatment now depends on Gleason pattern, pattern-four volume, and tumor genomics, so low-risk cancers go on active surveillance while higher-grade disease gets staging, surgery, radiation, or hormonal therapy, with fascia-sparing prostatectomy improving continence.
IDEAS WORTH REMEMBERING
5 ideasBehavioral and non-drug measures can meaningfully reduce nighttime urination.
Schaeffer says adjusting when and what you drink, wearing TED stockings if there is edema, and treating sleep apnea can cut nocturnal trips by about one, and Attia adds that alcohol worsens it.
HoLEP removes the whole inner adenoma and offers durable relief.
Using an orange analogy, Schaeffer contrasts scraping out pulp piecemeal with TURP against enucleating it in one piece along the natural plane, which bleeds less and often allows same-day discharge without a catheter.
Many chronic pelvic pain cases are not bacterial infections.
Schaeffer says a four-glass test can localize true infection, but many men instead have muscle tightness or inflammation, which respond to myofascial release, naproxen, and sometimes mast cell-targeted therapy in his father's trial.
5-alpha reductase inhibitors carry risks that Schaeffer does not recommend accepting.
He estimates about one in ten men have appreciable post-finasteride syndrome, and the drugs lower PSA by about half or more, so a rising PSA on them is a warning sign that is often missed.
A pre-biopsy MRI plus advanced PSA testing sharply improves screening.
Schaeffer cites a trial in which this pathway cut biopsies by 50% while improving detection of clinically significant cancer by 11%, and he advises a baseline PSA at 45 and tracking PSA density.
WORDS WORTH SAVING
5 quotesSo a normal prostate's a golf ball. An orange would be 100 grams. A big grapefruit's 400 grams.
— Ted Schaeffer
If your PSA rises on finasteride, you have a problem. That is a warning sign that there is a cancer, and likely an aggressive cancer, growing in your prostate.
— Ted Schaeffer
I think that there's a correlation between T and A being a healthy male, and part of being a healthy male is a potential risk for developing prostate cancer.
— Ted Schaeffer
I sure as hell see, with the existing technology, a reason for people not to be dying of colorectal cancer and men not to be dying of prostate cancer.
— Peter Attia
So a Gleason 7, as you said, again, the Gleason score is a Gleason sum, and it tells how much pattern three and how much pattern four do you have. So it is a blended scotch, not a single malt or whatever they call it, okay? And the blend is what matters the most.
— Ted Schaeffer
High quality AI-generated summary created from speaker-labeled transcript.
